Pharmacological modification of glutathione and NADP+ reduction.
D000328:Adult; D000375:Aging; D001241:Aspirin / Q000494:pharmacology; D001667:Binding, Competitive; D002701:Chloramphenicol / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D005978:Glutathione / Q000378:metabolism*; D005980:Glutathione Reductase / Q000037:antagonists & inhibitors; D006593:Hexokinase / Q000037:antagonists & inhibitors; D006801:Humans; D066298:In Vitro Techniques; D007231:Infant, Newborn; D007700:Kinetics; D007773:Lactates / Q000097:blood; D008706:Methemoglobin / Q000032:analysis; D009249:NADP / Q000378:metabolism*; D010084:Oxidation-Reduction; D010428:Pentosephosphates / Q000378:metabolism; D012459:Salicylates / Q000494:pharmacology
D007773:Lactates; D010428:Pentosephosphates; D012459:Salicylates; D009249:NADP; D002701:Chloramphenicol; D008706:Methemoglobin; D005954:Glucosephosphate Dehydrogenase; D005980:Glutathione Reductase; D006593:Hexokinase; D005978:Glutathione; D001241:Aspirin